D. O’Brien

22.8k total citations · 1 hit paper
236 papers, 14.7k citations indexed

About

D. O’Brien is a scholar working on Epidemiology, Infectious Diseases and Economics and Econometrics. According to data from OpenAlex, D. O’Brien has authored 236 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Epidemiology, 68 papers in Infectious Diseases and 48 papers in Economics and Econometrics. Recurrent topics in D. O’Brien's work include Mycobacterium research and diagnosis (54 papers), Tuberculosis Research and Epidemiology (34 papers) and Infectious Diseases and Mycology (26 papers). D. O’Brien is often cited by papers focused on Mycobacterium research and diagnosis (54 papers), Tuberculosis Research and Epidemiology (34 papers) and Infectious Diseases and Mycology (26 papers). D. O’Brien collaborates with scholars based in Australia, United Kingdom and United States. D. O’Brien's co-authors include Oliver E. Williamson, Greg Shaffer, Eugene Athan, Joseph Torresi, Steven C. Salop, Anthony McDonald, N. Deborah Friedman, Peter Callan, Leslie Shanks and Derryck Klarkowski and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

D. O’Brien

222 papers receiving 12.8k citations

Hit Papers

Markets and Hierarchies: Analysis and Antitrust Implicati... 1976 2026 1992 2009 1976 2.5k 5.0k 7.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. O’Brien Australia 42 5.0k 4.2k 2.2k 1.8k 1.8k 236 14.7k
Howard Thomas United States 68 6.6k 1.3× 1.9k 0.5× 2.5k 1.1× 119 0.1× 1.7k 1.0× 428 18.4k
Jeffrey D. Sachs United States 78 2.6k 0.5× 14.8k 3.6× 1.2k 0.5× 1.5k 0.8× 983 0.6× 431 38.8k
Philip C. Anderson United States 31 6.1k 1.2× 2.5k 0.6× 1.0k 0.5× 177 0.1× 487 0.3× 112 13.7k
Peter V. Marsden United States 46 2.9k 0.6× 1.5k 0.4× 1.1k 0.5× 330 0.2× 383 0.2× 105 15.5k
A. Colin Cameron United States 25 2.9k 0.6× 11.3k 2.7× 3.0k 1.4× 201 0.1× 591 0.3× 39 28.4k
John E. Butler United States 47 3.8k 0.8× 937 0.2× 1.0k 0.5× 734 0.4× 161 0.1× 168 11.0k
Everett M. Rogers United States 61 3.5k 0.7× 2.6k 0.6× 640 0.3× 236 0.1× 497 0.3× 241 27.7k
Robert M. Grant United States 82 20.4k 4.1× 4.5k 1.1× 3.7k 1.7× 12.0k 6.6× 6.5k 3.7× 478 45.8k
William C. Black United States 28 2.1k 0.4× 1.0k 0.2× 780 0.3× 221 0.1× 2.6k 1.5× 77 17.2k
Charles W. L. Hill United States 61 9.5k 1.9× 3.1k 0.8× 5.3k 2.4× 134 0.1× 210 0.1× 147 17.9k

Countries citing papers authored by D. O’Brien

Since Specialization
Citations

This map shows the geographic impact of D. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. O’Brien more than expected).

Fields of papers citing papers by D. O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. O’Brien. The network helps show where D. O’Brien may publish in the future.

Co-authorship network of co-authors of D. O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of D. O’Brien. A scholar is included among the top collaborators of D. O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. O’Brien. D. O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muhi, Stephen, Simone Schmidt, Julia L. Marshall, et al.. (2025). Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?. PLoS neglected tropical diseases. 19(2). e0012593–e0012593.
2.
Muhi, Stephen, Justina H. Hill, Anthony McDonald, et al.. (2025). Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement. The Medical Journal of Australia. 222(11). 571–578. 1 indexed citations
4.
Muhi, Stephen, et al.. (2024). An overview of Buruli ulcer in Australia. Australian Journal of General Practice. 53(9). 671–674. 4 indexed citations
5.
6.
McNamara, Bridgette, et al.. (2024). Prevalence, risk factors, and outcomes of secondary infections among hospitalized patients with COVID-19 or post–COVID-19 conditions in Victoria, 2020-2023. International Journal of Infectious Diseases. 145. 107078–107078. 5 indexed citations
7.
Blasdell, Kim R., Richard Ploeg, Emma C. Hobbs, et al.. (2024). Experimental infection of ringtail possums (Pseudocheirus peregrinus) with Mycobacterium ulcerans, the agent of Buruli ulcer. Scientific Reports. 14(1). 25352–25352. 1 indexed citations
8.
O’Brien, D. & Mark A. Israel. (2023). Vertical Mergers with Bilateral Contracting and Upstream and Downstream Investment. SSRN Electronic Journal.
9.
Majumdar, Suman, et al.. (2023). Effectiveness of community-based oral antiviral treatments against severe COVID-19 outcomes in people 70 years and over in Victoria, Australia, 2022: an observational study. The Lancet Regional Health - Western Pacific. 41. 100917–100917. 12 indexed citations
10.
O’Brien, D., Kim R. Blasdell, Stephen Muhi, et al.. (2023). Is BCG vaccination of possums the solution to the Buruli ulcer epidemic in south‐eastern Australia?. The Medical Journal of Australia. 219(11). 520–522. 7 indexed citations
11.
Röder, Christine, Bridgette McNamara, D. O’Brien, et al.. (2022). Area‐level social and economic factors and the local incidence of SARS‐CoV‐2 infections in Victoria during 2020. The Medical Journal of Australia. 216(7). 349–356. 16 indexed citations
12.
Ritacco, G., et al.. (2019). 171 Retrospective analysis of a subset of human repeat insult patch tests conducted by the Research Institute for Fragrance Materials over the past 30 years. Journal of Investigative Dermatology. 139(5). S30–S30. 1 indexed citations
13.
Morris, Lucy, et al.. (2019). Tuberculosis treatment unmasking leprosy: management of drug-resistant tuberculosis and leprosy co-infection. Public Health Action. 9(Supplement 1). S83–S85. 3 indexed citations
14.
O’Brien, D.. (2007). The development of monetary economics : a modern perspective on monetary controversies. E. Elgar eBooks. 4 indexed citations
15.
Cooper, James, Luke M. Froeb, D. O’Brien, & Michael Vita. (2005). Vertical Restrictions and Antitrust Policy: What About the Evidence?. RePEc: Research Papers in Economics. 1. 2 indexed citations
16.
Shaffer, Greg & D. O’Brien. (2005). Bargaining, Bundling, and Clout: The Portfolio Effects of Horizontal Mergers. The RAND Journal of Economics. 36(3). 573–595. 42 indexed citations
17.
O’Brien, D. & Abraham L. Wickelgren. (2003). A critical analysis of critical loss analysis. 71(1). 161–184. 24 indexed citations
18.
Salop, Steven C. & D. O’Brien. (2000). Competitive Effects of Partial Ownership: Financial Interest and Corporate Control. eYLS (Yale Law School). 189 indexed citations
19.
O’Brien, D., Roger E. Backhouse, & John Creedy. (1999). From classical economics to the theory of the firm : essays in honour of D.P. O'Brien. Edward Elgar eBooks. 14 indexed citations
20.
Kodres, Laura E. & D. O’Brien. (1993). The Existence of Pareto Superior Price Limits. American Economic Review. 84(4). 919–932. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026